Filing Details
- Accession Number:
- 0001209191-19-007373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-05 16:41:54
- Reporting Period:
- 2019-02-05
- Accepted Time:
- 2019-02-05 16:41:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Pharma Plc | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1667903 | M. Geoffrey Curtis | C/O Horizon Pharma Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp, Corporate Affairs, Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-02-05 | 5,500 | $23.11 | 32,202 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-02-05 | 2,000 | $23.25 | 30,202 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-02-05 | 1,335 | $23.20 | 28,867 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 420 | Indirect | By spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on December 13, 2018.
Billionaire Hedge Funds
